# Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders

> **NCT01141595** · NA · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 10 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** sapropterin dihydrochloride

## Key facts

- **NCT ID:** NCT01141595
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01141595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01141595, "Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01141595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*